KYTX · Kyverna Therapeutics, Inc. · Analyst Estimates
Market Cap
$448.98M
Shares
61.84M
Analyst Estimates
Compare analyst forecasts for Kyverna Therapeutics, Inc. across metrics and forecast periods.
Estimates are grouped by forecast period, with low, average and high together. A dash means that statistic is not available.
Only independently verified consensus published through the company's investor-relations sources is available.
Consensus not yet available
Only independently verified consensus published through the company's investor-relations sources is available.
Key facts
CIK
1994702
CUSIP
501976104
13F (30d)
62 filings
62 filers
Visit website
Investor relations